Abstract
Global prevalence of chronic kidney disease (CKD) has increased significantly, along with the annual death rate due to CKD and the associated high cost of treatment. Oral and maxillofacial impact is noted in the context of CKD. This chapter provides an overview of the oral and renal association and mechanisms through which oral disease contributes to CKD risk. Authors also present technological implications and various risk assessment tools that can be used in clinical practice. Further, the chapter highlights the advancing potential for translation of precision medicine approaches to the clinical arena to optimize CKD management across the disease spectrum to improve CKD detection and outcomes. Finally, the chapter identifies important gaps in clinical practice guidelines with respect to advancing integrated dental-medical care delivery due to absence of emphasis on potential oral-renal interactions which have been demonstrated and validated in the evidence base by systematic review.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abe D, Kubota T, Morozumi T, Shimizu T, Nakasone N, Itagaki M, Yoshie H. Altered gene expression in leukocyte transendothelial migration and cell communication pathways in periodontitis-affected gingival tissues. J Periodontal Res. 2011;46(3):345–53. https://doi.org/10.1111/j.1600-0765.2011.01349.x.
Araújo M, Hong B, Fava P, Khan S, Burleson J, Fares G, et al. End stage renal disease as a modifier of the periodontal microbiome. BMC Nephrol. 2015;16(1):80. https://doi.org/10.1186/s12882-015-0081-x.
Artese H, Sousa C, Torres M, Silva-Boghossian C, Colombo A. Effect of non-surgical periodontal treatment on the subgingival microbiota of patients with chronic kidney disease. Braz Oral Res. 2012;26(4):366–72. https://doi.org/10.1590/S1806-83242012005000008.
Atzler D, Schwedhelm E, Zeller T. Integrated genomics and metalomics in nephrology. Nephrol Dial Transplant. 2014;29:1467–74. https://doi.org/10.1093/ndt/gft492.
Centers for Disease Control and Prevention. Chronic kidney disease (CKD) surveillance project. 2018. https://nccd.cdc.gov/ckd/default.aspx. Accessed 10 June 2018.
Centers for Disease Control and Prevention. Chronic kidney disease basics. Chronic kidney disease initiative. CDC. 2017. https://www.cdc.gov/kidneydisease/basics.html. Accessed 30 Aug 2018.
Chen Z, Zhang X, Zhang Z. Clinical risk assessment of patients with chronic kidney disease by using clinical data and multivariate models. Int Urol Nephrol. 2016;48(12):2069–75. https://doi.org/10.1007/s11255-016-1346-4.
Cisek K, Krochmal M, Klein J, Mischak H. The application of multi-omics and systems biology to identify therapeutic targets in chronic kidney disease. Nephrol Dial Transplant. 2016;31(12):2003–11. https://doi.org/10.1093/ndt/gfv364.
Cole N, Liyanage H, Suckling R, Swift P, Gallagher H, Byford R, et al. An ontological approach to identifying cases of chronic kidney disease from routine primary care data: a cross-sectional study. BMC Nephrol. 2018;19(1):85. https://doi.org/10.1186/s12882-018-0882-9.
Corredor Z, Stoyanova E, Rodriguez-Ribera L, Coll E, Silva I, Diaz J, et al. Genomic damage as a biomarker of chronic kidney disease status. Environ Mol Mutagen. 2015;56:301–12. https://doi.org/10.1002/em.21911.
Davanian H, Stranneheim H, BÃ¥ge T, Lagervall M, Jansson L, Lundeberg J, Yucel-Lindberg T. Gene expression profiles in paired gingival biopsies from periodontitis-affected and healthy tissues revealed by massively parallel sequencing. PLoS One. 2012;7(9):e46440. https://doi.org/10.1371/journal.pone.0046440.
Davison S, Levin A, Moss AH, Jha V, Brown E, Brennan F, et al. Executive summary of the KDIGO Controversies Conference on Supportive Care in Chronic Kidney Disease: developing a roadmap to improving quality care. Kidney Int. 2015;88(3):447–59. https://doi.org/10.1038/ki.2015.110.
Drawz P, Archdeacon P, McDonald C, Powe N, Smith K, Norton J, et al. CKD as a model for improving chronic disease care through electronic health records. Clin J Am Soc Nephrol. 2015;10(8):1488–99. https://doi.org/10.2215/CJN.00940115.
Eke P, Dye B, Wei L, Slade G, Thornton-Evans G, Borgnakke W, et al. Update on prevalence of periodontitis in adults in the United States: NHANES 2009 to 2012. J Periodontol. 2015;86(5):611–22. https://doi.org/10.1902/jop.2015.140520.
Fricke W, Maddox C, Song Y, Bromberg J. Human microbiota characterization in the course of renal transplantation. Am J Transplant. 2014;14(2):416–27. https://doi.org/10.1111/ajt.12588.
Gheewala P, Peterson G, Zaidi S, Jose M, Castelino R. Evaluation of a chronic kidney disease risk assessment service in community pharmacies. Nephrology. 2018a; https://doi.org/10.1111/nep.13247.
Gheewala P, Peterson G, Zaidi S, Jose M, Castelino R. Public knowledge of chronic kidney disease evaluated using a validated questionnaire: a cross-sectional study. BMC Public Health. 2018b;18(1):371. https://doi.org/10.1186/s12889-018-5301-4.
Glassock R, Warnock D, Delanaye P. The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol. 2017;13(2):104–14. https://doi.org/10.1038/nrneph.2016.163.
Hill N, Fatoba S, Oke J, Hirst J, O’Callaghan C, Lasserson D, Hobbs F. Global prevalence of chronic kidney disease – a systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765. https://doi.org/10.1371/journal.pone.0158765.
Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–72. https://doi.org/10.1016/S0140-6736(13)60687-X.
Jolly S, Navaneethan S, Schold J, Arrigain S, Konig V, Burrucker YK, et al. Development of a chronic kidney disease patient navigator program. BMC Nephrol. 2015;16(1):69. https://doi.org/10.1186/s12882-015-0060-2.
KDIGO Workgroup. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1–150.
KDIGO. Guidelines. KDIGO; 2018. https://kdigo.org/guidelines/. Accessed 9 June 2018.
Kebschull M, Demmer R, Grün B, Guarnieri P, Pavlidis P, Papapanou PN. Gingival tissue transcriptomes identify distinct periodontitis phenotypes. J Dent Res. 2014;93(5):459–68. https://doi.org/10.1177/0022034514527288.
König J, Holtfreter B, Kocher T. Periodontal health in Europe: future trends based on treatment needs and the provision of periodontal services - position paper 1. Eur J Dent Educ. 2010;14:4–24. https://doi.org/10.1111/j.1600-0579.2010.00620.x.
Kornman K, Crane A, Wang H, di Giovine F, Newman M, Pirk F, et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol. 1997;24(1):72–7. http://www.ncbi.nlm.nih.gov/pubmed/9049801
Köttgen A, Hwang S-J, Larson MG, Van Eyk JE, Fu Q, Benjamin EJ, et al. Uromodulin levels associate with a common UMOD variant and risk for incident CKD. J Am Soc Nephrol. 2010a;21(2):337–44. https://doi.org/10.1681/ASN.2009070725.
Köttgen A, Pattaro C, Böger C, Fuchsberger C, Olden M, Glazer N, et al. New loci associated with kidney function and chronic kidney disease. Nat Genet. 2010b;42(5):376–84. https://doi.org/10.1038/ng.568.
Lee C, Lin C, Lin M, Lin S, Sung F, Kao C. Surgical treatment for patients with periodontal disease reduces risk of end-stage renal disease: a nationwide population-based retrospective cohort study. J Periodontol. 2014;85(1):50–6. https://doi.org/10.1902/jop.2013.130015.
Levey A, Coresh J, Balk E, Kausz A, Levin A, Steffes M, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139(2):137–47. http://www.ncbi.nlm.nih.gov/pubmed/12859163
Macedo Paizan M, Vilela-Martin J. Is there an association between periodontitis and hypertension? Curr Cardiol Rev. 2014;10(4):355–61. https://doi.org/10.2174/1573403X10666140416094901.
National Kidney Foundation. Global facts: about kidney disease. National Kidney Foundation; 2015. https://www.kidney.org/kidneydisease/global-facts-about-kidney-disease. Accessed 9 June 2018.
National Kidney Foundation. Global facts: about kidney disease. 2017. https://www.kidney.org/kidneydisease/global-facts-about-kidney-disease#_ENREF_3. Accessed 30 Aug 2018.
Navaneethan S, Schold J, Kirwan J, Arrigain S, Jolly S, Poggio ED, et al. Metabolic syndrome, ESRD, and death in CKD. Clin J Am Soc Nephrol. 2013;8(6):945–52. https://doi.org/10.2215/CJN.09870912.
NIDDK. Kidney disease statistics for the United States. NIDDK; 2018. https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease. Accessed 9 June 2018.
Nkuipou-Kenfack E, Duranton F, Gayrard N, Argilés À, Lundin U, Weinberger K, et al. Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease. PLoS One. 2014;9(5):e96955. https://doi.org/10.1371/journal.pone.0096955.
Ott SM, Elder G. Osteoporosis associated with chronic kidney disease. In: Osteoporosis. Amsterdan: Elsevier; 2013. p. 1387–424. https://doi.org/10.1016/B978-0-12-415853-5.00058-3.
Oyetola E, Owotade F, Agbelusi G, Fatusi O, Sanusi A. Oral findings in chronic kidney disease: implications for management in developing countries. BMC Oral Health. 2015;15(1):24. https://doi.org/10.1186/s12903-015-0004-z.
Pattaro C, Köttgen A, Teumer A, Garnaas M, Böger C, Fuchsberger C, et al. Genome-wide association and functional follow-up reveals new loci for kidney function. PLoS Genet. 2012;8(3):e1002584. https://doi.org/10.1371/journal.pgen.1002584.
Petersen P, Ogawa H. The global burden of periodontal disease: towards integration with chronic disease prevention and control. Periodontol 2000. 2012;60(1):15–39. https://doi.org/10.1111/j.1600-0757.2011.00425.x.
Pontes F, Lopes M, de Souza L, dos Santos da Mata Rezende D, Santos-Silva A, Jorge J, et al. Oral and maxillofacial manifestations of chronic kidney disease–mineral and bone disorder: a multicenter retrospective study. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(1):31–43. https://doi.org/10.1016/j.oooo.2017.09.011.
Pontillo C, Zhang Z, Schanstra J, Jacobs L, Zürbig P, Thijs L, et al. Prediction of chronic kidney disease stage 3 by CKD273, a urinary proteomic biomarker. Kidney Int Rep. 2017;2(6):1066–75. https://doi.org/10.1016/j.ekir.2017.06.004.
Ruospo M, Palmer S, Craig J, Gentile G, Johnson D, Ford P, et al. Prevalence and severity of oral disease in adults with chronic kidney disease: a systematic review of observational studies. Nephrol Dial Transplant. 2014;29(2):364–75. https://doi.org/10.1093/ndt/gft401.
Sagliker Y, Balal M, Sagliker Ozkaynak P, Paydas S, Sagliker C, Sabit Sagliker H, et al. Sagliker syndrome: uglifying human face appearance in late and severe secondary hyperparathyroidism in chronic renal failure. Semin Nephrol. 2004;24(5):449–55. http://www.ncbi.nlm.nih.gov/pubmed/15490409
Saran R, Hedgeman E, Plantinga L, Burrows N, Gillespie B, Young E, et al. Establishing a national chronic kidney disease surveillance system for the United States. Clin J Am Soc Nephrol. 2010;5(1):152–61. https://doi.org/10.2215/CJN.05480809.
Schena F. Biomarkers and personalized therapy in chronic kidney diseases. Expert Opin Investig Drugs. 2014;23(8):1051–4. https://doi.org/10.1517/13543784.2014.922953.
Smiley C, Tracy S, Abt E, Michalowicz B, John M, Gunsolley J, et al. Evidence-based clinical practice guideline on the nonsurgical treatment of chronic periodontitis by means of scaling and root planing with or without adjuncts. J Am Dent Assoc. 2015;146(7):525–35. https://doi.org/10.1016/j.adaj.2015.01.026.
Teumer A, Holtfreter B, Völker U, Petersmann A, Nauck M, Biffar R, et al. Genome-wide association study of chronic periodontitis in a general German population. J Clin Periodontol. 2013;40(11):977–85. https://doi.org/10.1111/jcpe.12154.
Trindade F, Oppenheim F, Helmerhorst E, Amado F, Gomes PS, Vitorino R. Uncovering the molecular networks in periodontitis. Proteomics Clin Appl. 2014;8(9–10):748–61. https://doi.org/10.1002/prca.201400028.
Tsakos G, Sabbah W, Hingorani A, Netuveli G, Donos N, Watt R, DʼAiuto F. Is periodontal inflammation associated with raised blood pressure? Evidence from a National US survey. J Hypertens. 2010;28(12):1. https://doi.org/10.1097/HJH.0b013e32833e0fe1.
Xu P, Gunsolley J. Application of metagenomics in understanding oral health and disease. Virulence. 2014;5(3):424–32. https://doi.org/10.4161/viru.28532.
Xu S, Song M, Xiong Y, Liu X, He Y, Qin Z. The association between periodontal disease and the risk of myocardial infarction: a pooled analysis of observational studies. BMC Cardiovasc Disord. 2017;17(1):50. https://doi.org/10.1186/s12872-017-0480-y.
Yang W, Jia Y, Wu H. Four tumor necrosis factor alpha genes polymorphisms and periodontitis risk in a Chinese population. Hum Immunol. 2013;74(12):1684–7. https://doi.org/10.1016/j.humimm.2013.08.009.
Zhang J, Jiang H, Sun M, Chen J. Association between periodontal disease and mortality in people with CKD: a meta-analysis of cohort studies. BMC Nephrol. 2017;18(1):269. https://doi.org/10.1186/s12882-017-0680-9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Glurich, I., Shimpi, N., Acharya, A. (2019). Interdisciplinary Care Model: Chronic Kidney Disease and Oral Health. In: Acharya, A., Powell, V., Torres-Urquidy, M., Posteraro, R., Thyvalikakath, T. (eds) Integration of Medical and Dental Care and Patient Data. Health Informatics. Springer, Cham. https://doi.org/10.1007/978-3-319-98298-4_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-98298-4_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-98296-0
Online ISBN: 978-3-319-98298-4
eBook Packages: MedicineMedicine (R0)